Showing results (51-60 of 91) with videos related to
Sort By:
Pageof 10
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1978
Efficacy of medical treatment of schistosomal obstructive uropathy as determined by 131I-Hippuran renographyS W Young, Z Farid, S Bassily, et al.Magnetic Resonance Imaging|January 1, 1990
Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agentS W Young, B Bradley, H H Muller, et al.Investigative Radiology|June 1, 1996
Experimental acute cerebral ischemia with reperfusion. Evaluation with gadolinium-texaphyrinS W Young, Q Fan, D M Kunis, et al.Investigative Radiology|November 1, 1991
Solid-state phosphorus-31 nuclear magnetic resonance differentiation of bone mineral and synthetic apatite used to fill bone defectsK L Dawson, I E Farnan, B R Constantz, et al.AJR. American Journal of Roentgenology|July 1, 1981
Perfluoroctylbromide contrast enhancement of malignant neoplasms: preliminary observationsS W Young, D R Enzmann, D M Long, et al.The Journal of Investigative Dermatology|May 14, 1998
Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrinK W Woodburn, Q Fan, D Kessel, et al.Radiology|April 1, 1992
Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivityM E Bernardino, S W Young, J K Lee, et al.Journal of Computer Assisted Tomography|August 1, 1981
Cancer imaging by scanned projection radiographyD M Cassel, S W Young, W R Brody, et al.Magnetic Resonance in Medicine|April 1, 1989
MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelateS W Young, B B Simpson, A V Ratner, et al.Investigative Radiology|October 1, 1993
Manganese dipyridoxal diphosphate-enhanced magnetic resonance imaging in the evaluation of hepatocyte functionM K Sidhu, H H Muller, J Aggeler, et al.Pageof 10